5mg

AOD-9604

5mg

90.00$

AOD-9604 is studied for its relationship to fat metabolism signaling pathways. Researchers explore how this peptide may influence how cells regulate fat storage and breakdown without broadly activating growth hormone pathways.

AOD-9604

Product Name: AOD-9604
Type: Fat Metabolism Research Peptide

 

Research Focus:

AOD-9604 dosage protocols leverage this synthetic 16‑amino‑acid fragment (Tyr‑hGH 177–191) to support lipolysis (fat breakdown) and inhibit lipogenesis (fat storage) without elevating IGF‑1 levels or causing insulin resistance[1][2]. Clinical trials have demonstrated that AOD‑9604 exhibits a placebo‑like safety profile in obese adults, making it a well‑tolerated option for metabolic support[3]. This educational protocol outlines a once‑daily subcutaneous approach using a practical dilution for clear insulin‑syringe measurements.

 

Research Interest:

  • Fat breakdown signaling studies

  • Adipose tissue regulation models

  • Metabolic efficiency research

  • Body composition signaling pathways

 

Scientific Interest:

  • Lipid metabolism signaling networks

  • Energy balance regulation mechanisms

  • Adipocyte cellular response studies


Reconstitution:

  • Reconstitute: Add 3.0 mLbacteriostatic water → ~1.667 mg/mL(1667 mcg/mL) concentration.

  • Typical daily range: 300–500 mcgonce daily (gradual titration).

  • Easy measuring: At 1.667 mg/mL, 1 unit = 0.01 mL ≈ 16.67 mcg on a U‑100 insulin syringe.

  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

 

Cycle:

Standard / Gradual Approach (3 mL = ~1.667 mg/mL)

WEEK

DAILY DOSE (MCG)

UNITS (PER INJECTION) (ML)

Weeks 1–4

300 mcg

18 units (0.18 mL)

Weeks 5–12

500 mcg

30 units (0.30 mL)

 

Frequency: Inject once daily subcutaneously (typically in the morning on an empty stomach). This schedule uses the largest practical dilution (3.0 mL) to keep per‑injection units ≥10 for better accuracy. Rotate injection sites (abdomen, thighs, upper arms) to minimize local irritation.

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.

  2. Inject slowly down the vial wall; avoid foaming.

  3. Gently swirl/roll until dissolved (do not shake).

  4. Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.


IMPORTANT NOTICE:

This product is intended strictly for laboratory research. It is not intended to diagnose, treat, cure, or prevent any disease.

King St. West,
Toronto, Ontario
Canada.

M6K 3M3